14 results
6-K
EX-99.1
NLSP
NLS Pharmaceutics Ltd
15 Apr 24
Report of Foreign Private Issuer
4:01pm
oder der Geschäftsleitung kann mehr als fünf solche Mandate wahrnehmen.
Mandates in associations, charitable organizations, foundations, trusts
6-K
EX-99.1
NLSP
NLS Pharmaceutics Ltd
14 Mar 24
Report of Foreign Private Issuer
9:00am
oder der Geschäftsleitung kann mehr als fünf solche Mandate wahrnehmen.
Mandates in associations, charitable organizations, foundations, trusts
6-K
EX-99.1
NLSP
NLS Pharmaceutics Ltd
13 Dec 22
Report of Foreign Private Issuer
7:31pm
Mandate wahrnehmen.
b) Mandates in associations, charitable organizations, foundations, trusts and employee welfare foundation. No member
6-K
EX-99.1
NLSP
NLS Pharmaceutics Ltd
28 Oct 22
Report of Foreign Private Issuer
4:00pm
Mandate wahrnehmen.
b) Mandates in associations, charitable organizations, foundations, trusts and employee welfare foundation. No member
6-K
EX-3.1
NLSP
NLS Pharmaceutics Ltd
7 Oct 22
Report of Foreign Private Issuer
4:01pm
wahrnehmen.
b) Mandates in associations, charitable organizations, foundations, trusts and employee welfare foundation. No member of the board of directors
6-K
EX-3.1
k6kywo4a
16 Sep 22
Report of Foreign Private Issuer
4:30pm
6-K
EX-3.1
r9kzgwqxc 8dfaxap
3 Jun 22
Report of Foreign Private Issuer
5:00pm
6-K
EX-3.1
wn9in5
14 Dec 21
Report of Foreign Private Issuer
4:59pm
6-K
EX-3.1
w2o6ca 8cahxw1
23 Nov 21
Report of Foreign Private Issuer
7:11am
6-K
EX-3.1
2lkglecri rjvd
26 Oct 21
Report of Foreign Private Issuer
4:00pm
6-K
EX-3.1
orjbt f7d
9 Feb 21
Report of Foreign Private Issuer
12:00am
6-K
EX-3.2
50a6fvpcz zk4jyu
9 Feb 21
Report of Foreign Private Issuer
12:00am
6-K
EX-3.1
hi9bfdxjoamz mumcc
2 Feb 21
NLS Pharmaceutics Ltd. Announces Closing of $20.0 Million Initial Public Offering
5:29pm
F-1/A
EX-3.1
7xmddrt80l1cy5
16 Oct 20
Registration statement (foreign) (amended)
9:59pm
- Prev
- 1
- Next